KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy
Resource Type
Article
Authors
Favazza, Laura A. ; Parseghian, Christine M. ; Kaya, Cihan ; Nikiforova, Marina N. ; Roy, Somak ; Wald, Abigail I. ; Landau, Michael S. ; Proksell, Siobhan S. ; Dueker, Jeffrey M. ; Johnston, Elyse R. ; Brand, Randall E. ; Bahary, Nathan ; Gorantla, Vikram C. ; Rhee, John C. ; Pingpank, James F. ; Choudry, Haroon A. ; Lee, Kenneth ; Paniccia, Alessandro ; Ongchin, Melanie C. ; Zureikat, Amer H. ; Bartlett, David L. ; Singhi, Aatur D.
Source
In Modern Pathology September 2020 33(9):1832-1843
Subject
Language
ISSN
0893-3952